|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-8-8
|
|
pubmed:abstractText |
Coccidioidomycosis can be difficult to treat with available therapies, particularly in patients with progressive or disseminated disease. Posaconazole is a new azole antifungal with potent activity against Coccidioides species, the causative agent of coccidioidomycosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
pubmed-author:CatanzaroAntoninoA,
pubmed-author:CloudGretchen AGA,
pubmed-author:GalgianiJohn NJN,
pubmed-author:HollowayMelissaM,
pubmed-author:JohnsonRoyce HRH,
pubmed-author:LevineBernard EBE,
pubmed-author:LutzJon EJE,
pubmed-author:MirelsLaurence FLF,
pubmed-author:RendonAdrianA,
pubmed-author:StevensDavid ADA,
pubmed-author:WilliamsPaul LPL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
562-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17682989-Adult,
pubmed-meshheading:17682989-Aged,
pubmed-meshheading:17682989-Antifungal Agents,
pubmed-meshheading:17682989-Coccidioidomycosis,
pubmed-meshheading:17682989-Female,
pubmed-meshheading:17682989-Humans,
pubmed-meshheading:17682989-Lung Diseases, Fungal,
pubmed-meshheading:17682989-Male,
pubmed-meshheading:17682989-Middle Aged,
pubmed-meshheading:17682989-Recurrence,
pubmed-meshheading:17682989-Severity of Illness Index,
pubmed-meshheading:17682989-Treatment Outcome,
pubmed-meshheading:17682989-Triazoles
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
|
|
pubmed:affiliation |
University of California San Diego, San Diego, CA 92103, USA. acatanzaro@ucsd.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
